-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dexmedetomidine in Alcohol Dependence
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dexmedetomidine in Alcohol Dependence report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dexmedetomidine in Alcohol Dependence Drug Details: Dexmedetomidine (Igalmi) is an imidazole derivate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ibudilast in Alcohol Dependence
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ibudilast in Alcohol Dependence report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ibudilast in Alcohol Dependence Drug Details: Ibudilast (Ketas) is an anti-inflammatory and...
-
New
Likelihood of Approval and Phase Transition Success Rate Model – PT-150 in Alcohol Dependence
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PT-150 in Alcohol Dependence report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PT-150 in Alcohol Dependence Drug Details: PT-150 is under development for the...
-
Analyst Opinions
Alcoholic Beverages Demand Spaces and Top Trends – Industry Insights
There are seven global trends—Setting the Bar Low, Picking Premium, Toasting Transparency, Digital Connoisseurs, A Glass for Everyone, Not Going Out, and Ones to Watch—all of which are predicted to shape and influence the market for alcoholic drinks in 2024. "Industry Insights: Alcoholic Beverages Demand Spaces and Top Trends" explores upcoming trends in the global market for alcoholic beverages and their demand spaces. Demand spaces are an iteration of the longstanding analytical mode based around the "five Ws": the who, what, when, where,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Edetate Disodium + Ethyl Alcohol + Minocycline Hydrochloride) in Fungal Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Edetate Disodium + Ethyl Alcohol + Minocycline Hydrochloride) in Fungal Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Edetate Disodium + Ethyl Alcohol...
-
Analyst Opinions
Non-Alcoholic Beverages Demand Spaces and Top Trends – Industry Insights
Non-Alcoholic Beverages Demand Spaces and Top Trends Report Overview In the market for non-alcoholic beverages (NABs), consumers are influenced by global trends to seek more personalized, functional, and innovative products that will satisfy their demands on a more sensory level. The non-alcoholic beverages demand spaces and the top trends report explores the trend-sight overview such as setting the bar low, not going out, picking premium, and others. This report helps the market players, non-alcoholic beverages operators, to understand consumer needs...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Edetate Disodium + Ethyl Alcohol + Minocycline Hydrochloride) in Staphylococcus aureus Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Edetate Disodium + Ethyl Alcohol + Minocycline Hydrochloride) in Staphylococcus aureus Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Edetate Disodium + Ethyl...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Edetate Disodium + Ethyl Alcohol + Minocycline Hydrochloride) in Pseudomonas aeruginosa Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Edetate Disodium + Ethyl Alcohol + Minocycline Hydrochloride) in Pseudomonas aeruginosa Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Edetate Disodium + Ethyl...
-
Product Insights
NewAlcoholic Hepatitis – Drugs In Development, 2024
Empower your strategies with our Alcoholic Hepatitis – Drugs In Development, 2024 report and make more profitable business decisions. Alcoholic hepatitis is inflammation of the liver caused by excessive alcohol consumption over a long period of time. Symptoms include changes in appetite, dry mouth, weight loss, yellowing of the skin or eyes (jaundice), fever, and fatigue. Risk factors include alcohol use, obesity, and genetic factors. Treatment includes corticosteroids and liver transplant. The Alcoholic Hepatitis drugs in development market research report provide...
-
Product Insights
NewAlcohol Addiction – Drugs In Development, 2024
Empower your strategies with our Alcohol Dependence – Drugs In Development, 2024 report and make more profitable business decisions. Alcohol addiction refers to a psychological and physical dependency on alcohol. Symptoms include decreased involvement in extracurricular activities, depression, restlessness, inability to control drinking, and violent behavior. Risk factors include age, family history, and depression or other mental health problems. The Alcohol Dependence drugs in development market research report provide comprehensive information on the therapeutics under development for Alcohol Dependence, complete with...